Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Metastasis is the ultimate villain in the story of cancer. It is the moment a localized rebellion becomes a systemic war, and it is responsible for the vast majority of cancer-related deaths. For years, the process of metastasis remained a…
In the quiet, climate-controlled archives of pathology labs worldwide, millions of small, wax-embedded blocks sit in neat rows. To the uninitiated, they are inert, historical artifacts—remnants of a diagnostic process completed long ago. But to the modern oncologist and researcher,…
There exists a peculiar and profound artifact in the realm of medical research: a melanoma tissue array annotated with survival data. It is not merely a scientific tool; it is a Mirror of Fates. Each tiny core of tissue, a…
To the uninitiated, it is a sliver of glass, stained with a wash of pinks and purples, a seemingly abstract watercolor. But to the pathologist, it is a map. Not of lands or oceans, but of a human soul’s final,…
Imagine, if you will, a library unlike any other. Its shelves do not hold books of parchment and ink, but paraffin blocks embedding the very fabric of life and its corruption. Each volume is a Tissue Microarray (TMA), a condensed…
In the quest to conquer cancer, data is our most powerful ally. Yet, data, when stripped of its human context, can feel cold and abstract. We speak of Kaplan-Meier curves, hazard ratios, and statistical significance, but behind these numbers lie…
In the digital age of algorithms and artificial intelligence, there remains a domain where the human eye, trained to a degree of almost preternatural perception, is the ultimate arbiter of truth. This is the world of surgical pathology, and its…
In the vast and often bewildering landscape of cancer research, the individual tumor has long been studied as a solitary mountain—unique, formidable, and requiring a full expedition to understand. While this approach has yielded invaluable insights, it has also been…
Rare cancers, by definition, present a formidable challenge: the scarcity of high-quality, clinically annotated tissue samples. This scarcity severely hinders biomarker discovery, therapeutic target validation, and the development of diagnostic tools, leaving patients with limited options. Traditional Tissue Microarrays (TMAs),…
Tissue Microarrays (TMAs) revolutionized immunohistochemistry (IHC) by enabling the simultaneous analysis of tens to hundreds of tissue cores on a single slide. Their primary recognized value lies in high-throughput screening: rapidly validating biomarkers across large cohorts, assessing inter-observer variability, or…
